Condition
Cerumen Impaction of Both Ears
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04653662Not ApplicableCompletedPrimary
Earol Madrid Study
NCT04743817Not ApplicableCompletedPrimary
Feasibility Evaluation of OtoSet
NCT02829294Not ApplicableCompletedPrimary
Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)
NCT04094116Not ApplicableUnknownPrimary
Comparison of Effectiveness of Ear Syringing With or Without Pre-Ear Oil Application , Non-randomized Control Trial.
NCT03802903Not ApplicableCompletedPrimary
Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax
Showing all 5 trials